Direct, acute effects of Klotho and FGF23 on vascular smooth muscle and endothelium

PLoS ONE

Volumn 9, Issue 4, 2014, Pages

  Six, Isabelle ^a   Okazaki, Hirokazu ^a   Gross, Priscilla ^a   Cagnard, Joanna ^a   Boudot, Cédric ^a   Maizel, Julien ^a,b   Drueke, Tilman B ^a   Massy, Ziad A ^a,b  

^a UNIVERSITÉ DE PICARDIE JULES VERNE   (France)

^b AMIENS UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOTHELIAL NITRIC OXIDE SYNTHASE; FIBROBLAST GROWTH FACTOR 23; INDUCIBLE NITRIC OXIDE SYNTHASE; KLOTHO PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; NITRIC OXIDE; PHOSPHATE; REACTIVE OXYGEN METABOLITE; BETA GLUCURONIDASE; FIBROBLAST GROWTH FACTOR; NITROGEN OXIDE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL TONE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; MOUSE; MUSCLE CONTRACTILITY; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; SMOOTH MUSCLE RELAXATION; VASCULAR ENDOTHELIUM; VASCULAR SMOOTH MUSCLE; VASOCONSTRICTION; ANIMAL; AORTA; C57BL MOUSE; CHRONIC KIDNEY FAILURE; DRUG EFFECTS; METABOLISM; PHYSIOLOGY; RADIATION RESPONSE; UMBILICAL VEIN ENDOTHELIAL CELL; VASODILATATION;

ANIMALS; AORTA; ENDOTHELIUM, VASCULAR; FEMALE; FIBROBLAST GROWTH FACTORS; GLUCURONIDASE; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; MICE; MICE, INBRED C57BL; MUSCLE, SMOOTH, VASCULAR; NITROGEN OXIDES; PHOSPHATES; RENAL INSUFFICIENCY, CHRONIC; VASOCONSTRICTION; VASODILATION;

EID: 84898860573     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0093423     Document Type: Article

References (28)

1. Keith DS, Nichols GA, Gullion CM, Brown JB, Smith DH (2004) Longitudinal follow-up and outcomes among a population with chronic kidney disease in a large managed care organization. Arch Intern Med 164:659-663. (Pubitemid 38392981)
2. Stam F, van Guldener C, Becker A, Dekker JM, Heine RJ, et al. (2006) Endothelial dysfunction contributes to renal function-associated cardiovascular mortality in a population with mild renal insufficiency: the Hoorn study. J Am Soc Nephrol 17:537-545.
3. Recio-Mayoral A, Banerjee D, Streather C, Kaski JC (2011) Endothelial dysfunction, inflammation and atherosclerosis in chronic kidney disease - a cross-sectional study of predialysis, dialysis and kidney-transplantation patients. Atherosclerosis 216:446-451
4. Montezano AC, Touyz RM (2012) Reactive oxygen species and endothelial function - role of nitric oxide synthase uncoupling and Nox family nicotinamide adenine dinucleotide phosphate oxidases. Basic Clin Pharmacol Toxicol 110:87-94.
5. Matsumura Y, Aizawa H, Shiraki-Iida T, Nagai R, Kuro-o M, et al. (1998) Identification of the human klotho gene and its two transcripts encoding membrane and secreted klotho protein. Biochem Biophys Res Commun 242:626-630. (Pubitemid 28412578)
6. Prié D, Ureña Torres P, Friedlander G (2009) Latest findings in phosphate homeostasis. Kidney Int 75:882-889.
7. Lim K, Lu TS, Molostvov G, Lee C, Lam FT, et al. (2012) Vascular Klotho deficiency potentiates the development of human artery calcification and mediates resistance to fibroblast growth factor 23. Circulation 125:2243-2255.
8. Quarles LD (2008) Endocrine functions of bone in mineral metabolism regulation. J Clin Invest 118:3820-3828.
9. Nakai K, Komaba H, Fukagawa M (2010) New insights into the role of fibroblast growth factor 23 in chronic kidney disease. J Nephrol 23:619-625.
10. Saito T, Fukumoto S (2009) Fibroblast Growth Factor 23 (FGF23) and Disorders of Phosphate Metabolism. Int J Pediatr Endocrinol 2009:496514.
11. Kuro-o M, Matsumura Y, Aizawa H, Kawaguchi H, Suga T, et al. (1997) Mutation of the mouse klotho gene leads to a syndrome resembling ageing. Nature 390:45-51. (Pubitemid 27494749)
12. Shimada T, Kakitani M, Yamazaki Y, Hasegawa H, Takeuchi Y, et al. (2004) Targeted ablation of Fgf23 demonstrates an essential physiological role of FGF23 in phosphate and vitamin D metabolism. J Clin Invest 113:561-568. (Pubitemid 38542505)
13. Galitzer H, Ben-Dov IZ, Silver J, Naveh-Many T (2010) Parathyroid cell resistance to fibroblast growth factor 23 in secondary hyperparathyroidism of chronic kidney disease. Kidney Int 77:211-218.
14. Canalejo R, Canalejo A, Martinez-Moreno JM, Rodriguez-Ortiz ME, Estepa JC, et al. (2010) FGF23 fails to inhibit uremic parathyroid glands. J Am Soc Nephrol 21:1125-1135.
15. Faul C, Amaral AP, Oskouei B, Hu MC, Sloan A, et al. (2011) FGF23 induces left ventricular hypertrophy. J Clin Invest 121:4393-4408.
16. Mirza MA, Larsson A, Lind L, Larsson TE (2009) Circulating fibroblast growth factor-23 is associated with vascular dysfunction in the community. Atherosclerosis 205:385-390.
17. Saito Y, Yamagishi T, Nakamura T, Ohyama Y, Aizawa H, et al. (1998) Klotho protein protects against endothelial dysfunction. Biochem Biophys Res Commun 248:324-329. (Pubitemid 28386420)
18. Saito Y, Nakamura T, Ohyama Y, Suzuki T, Iida A, et al. (2000) In vivo klotho gene delivery protects against endothelial dysfunction in multiple risk factor syndrome. Biochem Biophys Res Commun 276:767-772.
19. Six I, Maizel J, Barreto FC, Rangrez AY, Dupont S, et al. (2012) Effects of phosphate on vascular function under normal conditions and influence of the uraemic state. Cardiovasc Res 96:130-139.
20. Rakugi H, Matsukawa N, Ishikawa K, Yang J, Imai M, et al. (2007) Antioxidative effect of Klotho on endothelial cells through cAMP activation. Endocrine 31(1):82-87. (Pubitemid 350194199)
21. Yang K, Nie L, Huang Y, Zhang J, Xiao T, et al. (2012) Amelioration of uremic toxin indoxyl sulfate-induced endothelial cell dysfunction by Klotho protein. Toxicol Lett 215:77-83.
22. Carracedo J, Buendía P, Merino A, Madueño JA, Peralbo E, et al. (2012) Klotho modulates the stress response in human senescent endothelial cells. Mech Ageing Dev 133:647-654.
23. Nakamura T, Saito Y, Ohyama Y, Masuda H, Sumino H, et al. (2002) Production of nitric oxide, but not prostacyclin, is reduced in klotho mice. Jpn J Pharmacol 89:149-156. (Pubitemid 34752300)
24. Izquierdo MC, Perez-Gomez MV, Sanchez-Niño MD, Sanz AB, Ruiz-Andres O, et al. (2012) Klotho, phosphate and inflammation/ageing in chronic kidney disease. Nephrol Dial Transplant 27 Suppl 4:iv6-10.
25. Hu MC, Shi M, Zhang J, Quiñones H, Griffith C, et al. (2011) Klotho deficiency causes vascular calcification in chronic kidney disease. J Am Soc Nephrol 22:124-136.
26. Nagano N, Miyata S, Abe M, Kobayashi N, Wakita S, et al. (2006) Effect of manipulating serum phosphorus with phosphate binder on circulating PTH and FGF23 in renal failure rats. Kidney Int 69:531-537. (Pubitemid 43164446)
27. Lindberg K, Olauson H, Amin R, Ponnusamy A, Goetz R, et al. (2013) Arterial Klotho Expression and FGF23 Effects on Vascular Calcification and Function. PLoS One 8(4):e60658.
28. Agarwal I, Ide N, Ix JH, Kestenbaum B, Lanske B, et al. (2014) Fibroblast growth factor-23 and cardiac structure and function. J Am Heart Assoc 3(1):e000584.